Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Hydrocortisone acetate
Drug ID BADD_D01087
Description Not Available
Indications and Usage For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.
Marketing Status approved; vet_approved
ATC Code Not Available
DrugBank ID DB14539
KEGG ID D00165
MeSH ID C021650
PubChem ID 5744
TTD Drug ID Not Available
NDC Product Code 10135-751; 11509-5101; 24689-102; 50332-0042; 53002-3440; 65649-511; 24002-0035; 64025-0002; 16571-676; 42494-342; 47682-207; 47682-923; 58443-0411; 65649-411; 58624-0704; 61907-021; 16477-202; 47832-205; 50090-6331; 55681-224; 63629-2530; 58443-0412; 69367-243; 71927-015; 0713-0493; 51552-0021; 59929-109; 60722-1004; 64958-0034; 11822-2069; 0037-6830; 0574-7090; 71927-018; 79503-103; 38779-0008; 51927-0196; 71216-3005; 39328-029; 42494-341; 49873-703; 63629-2531; 69680-144; 82637-9455; 0574-0421; 49452-3590; 58624-0706; 39328-129; 51407-665; 70752-169; 0574-7093; 58624-0705; 51672-2069; 58443-0246; 63629-1994; 73598-1014; 22552-0036; 16477-201; 24689-103; 51672-3009; 68071-2259; 71205-976; 0713-0503; 0009-5161; 51927-1110; 64958-0098; 0363-0972; 50268-411
UNII 3X7931PO74
Synonyms hydrocortisone acetate | cortisol 21-acetate | hydrocortisone 21-acetate | Colifoam | Cortifoam | hydrocortisone acetate, monoammonium salt, (11beta)-isomer | hydrocortisone acetate, (11alpha)-isomer | hydrocortisone acetate, (11beta)-isomer | hydrocortisone acetate, (11beta,17alpha)-isomer | hydrocortisone acetate, sodium salt | Epifoam
Chemical Information
Molecular Formula C23H32O6
CAS Registry Number 50-03-3
SMILES CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Malaise08.01.01.003--
Nasal congestion22.04.04.001--
Nephrolithiasis20.04.01.002--
Oedema08.01.07.006; 14.05.06.010--Not Available
Oedema peripheral14.05.06.011; 08.01.07.007; 02.05.04.007--
Pain08.01.08.004--
Pain in extremity15.03.04.010--
Paraesthesia23.03.03.094; 17.02.06.005--
Pruritus23.03.12.001--
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Rash erythematous23.03.13.029--Not Available
Rectal haemorrhage24.07.02.018; 07.12.03.001--
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Therapeutic response decreased08.06.01.016--Not Available
Vision blurred17.17.01.010; 06.02.06.007--
Visual impairment06.02.10.013--Not Available
Poor venous access24.03.02.017--Not Available
Rectal discharge07.03.03.005--Not Available
General physical health deterioration08.01.03.018--Not Available
Haemorrhage24.07.01.002--Not Available
Cardiac disorder02.11.01.003--Not Available
Therapeutic reaction time decreased08.06.01.015--Not Available
Decreased appetite08.01.09.028; 14.03.01.005--
Bowel movement irregularity07.02.03.003--Not Available
Treatment failure08.06.01.017--Not Available
Oropharyngeal pain22.12.03.016; 07.05.05.004--
Burning sensation mucosal08.01.06.020; 17.02.06.031--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages